Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Sickle cell and thalassaemia screening programme lab support service

The purpose of the service is to provide technical and scientific support to UK Sickle Cell and Thalassaemia screening service via email and telephone advice lines and teaching/training days.

The service is commissioned by the National Sickle Cell and Thalassaemia Screening Programme.

Most enquiries come from staff in haemoglobinopathy screening laboratories, but we are also very happy to answer queries from any other health professional requiring advice interpreting haemoglobinopathy laboratory results.

We can try to help with all aspects of the laboratory diagnosis of haemoglobinopathy (see FAQs in 'Links' section) but areas we are often asked about include:

  • Interpretation of HPLC, FBC, results and electrophoresis results
  • Interpretation of borderline results
  • Information concerning alpha thalassaemia phenotypes/genotypes
  • Information concerning HPFH/delta-beta thalassaemia phenotypes
  • When partner testing should be recommended
  • How results should be reported when the results are not clear cut
  • When samples should be referred for further testing (e.g., mass spectrometry or genetic testing)
  • When results should be referred to clinical staff
  • The clinical significance of rare haemoglobin variants

For more details about the service please visit Population screening programmes: detailed information.

Contact us

Tel: 01865 572769


Some reference materials can be found below:

Last reviewed:02 August 2021